High-dose melphalan in patients with multiple myeloma

被引：0
作者：
Moreau, P
Le Bonniec, M
Harousseau, JL
机构：
[1] CHU Hotel Dieu, Serv Hematol Clin, F-44093 Nantes, France
[2] Lab Glaxo Wellcome, F-78163 Marly Le Roi, France
来源：
BULLETIN DU CANCER | 1999年 / 86卷 / 03期
关键词：
melphalan; multiple myeloma; autologous stem cell transplantation;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Since 1983 an increasing number of clinical trials have used high-dose melphalan with or without autologous stem cell support in patients with multiple myeloma. It has been shown that high-dose therapy including high-dose melphalan may be considered as the treatment of choice in newly diagnosed patients. The purpose of this report is to review and summarize the clinical information on IV high-dose melphalan in patients with multiple myeloma and to examine potential areas of future investigation.
引用
收藏
页码：283 / 288
页数：6
相关论文
共 42 条
  • [1] ALEXANIAN R, 1994, BLOOD, V83, P512
  • [2] TREATMENT FOR MULTIPLE MYELOMA - COMBINATION CHEMOTHERAPY WITH DIFFERENT MELPHALAN DOSE REGIMENS
    ALEXANIAN, R
    HAUT, A
    KHAN, AU
    LANE, M
    MCKELVEY, EM
    MIGLIORE, PJ
    STUCKEY, WJ
    WILSON, HE
    [J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1969, 208 (09) : 1680 - +
  • [3] A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma
    Attal, M
    Harousseau, JL
    Stoppa, AM
    Sotto, JJ
    Fuzibet, JG
    Rossi, JF
    Casassus, P
    Maisonneuve, H
    Facon, T
    Ifrah, N
    Payen, C
    Bataille, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (02) : 91 - 97
  • [4] INTENSIVE COMBINED THERAPY FOR PREVIOUSLY UNTREATED AGGRESSIVE MYELOMA
    ATTAL, M
    HUGUET, F
    SCHLAIFER, D
    PAYEN, C
    LAROCHE, M
    FOURNIE, B
    MAZIERES, B
    PRIS, J
    LAURENT, G
    [J]. BLOOD, 1992, 79 (05) : 1130 - 1136
  • [5] ATTAL M, 1998, AM SOC HEMATOLOGY
  • [6] BARLOGIE B, 1987, BLOOD, V70, P869
  • [7] HIGH-DOSE MELPHALAN AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FOR REFRACTORY MULTIPLE-MYELOMA
    BARLOGIE, B
    JAGANNATH, S
    DIXON, DO
    CHESON, B
    SMALLWOOD, L
    HENDRICKSON, A
    PURVIS, JD
    BONNEM, E
    ALEXANIAN, R
    [J]. BLOOD, 1990, 76 (04) : 677 - 680
  • [8] BARLOGIE B, 1986, BLOOD, V67, P1298
  • [9] Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma
    Barlogie, B
    Jagannath, S
    Vesole, DH
    Naucke, S
    Cheson, B
    Mattox, S
    Bracy, D
    Salmon, S
    Jacobson, J
    Crowley, J
    Tricot, G
    [J]. BLOOD, 1997, 89 (03) : 789 - 793
  • [10] BARLOGIE B, 1988, BLOOD, V72, P215
12345